GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646…
ZÜRICH and PORTO, Portugal, July 1, 2025 /PRNewswire/ -- Altri SGPS S.A. (ALTR.LS), a Portuguese-listed leader in sustainable cellulosic pulp…
Genesis Magma Racing drivers and team members took valuable lessons from first involvement in 24 Hours of Le Mans, working…
HYDERABAD, India, June 11, 2025 /PRNewswire/ -- Woxsen University has been recognised once again as a Level 5 'Pioneering' School…
The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel anti-cancer…
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced…